VanEck Pharmaceutical ETF (PPH) News Today $88.23 -1.13 (-1.26%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$88.24 +0.01 (+0.01%) As of 07/11/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock PPH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And CenterJuly 7, 2025 | seekingalpha.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6069July 1, 2025 | msn.comGlobal pharma stocks down as Trump renews tariff threatJune 17, 2025 | msn.comPPH, Big Pharma Stocks Volatile on Trump Drug PricingMay 14, 2025 | finance.yahoo.comPPH: Will Overcome Tariffs, But Competitor Funds Look StrongerApril 14, 2025 | seekingalpha.comBig Pharma higher after tariff exemption despite ongoing uncertaintiesApril 3, 2025 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.4110December 27, 2024 | msn.comThe Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNROctober 17, 2024 | finance.yahoo.comDiversified Exposure To The Weight Loss Drug MarketOctober 10, 2024 | seekingalpha.comPharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPHOctober 3, 2024 | seekingalpha.comAbbVie stock analysis: Rinvoq and Skyrizi are big catalystsOctober 1, 2024 | msn.comThis Canadian ETF could be a play on the changing fortunes of U.S. Mid-CapsSeptember 20, 2024 | theglobeandmail.comTeva Pharmaceutical hits a new 52-week highAugust 14, 2024 | msn.comPPH: A Strong Fund To Play Big PharmaJuly 18, 2024 | seekingalpha.comJust Say No to Drugs: 3 Pharma Stocks to AvoidMay 8, 2024 | msn.comPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsApril 23, 2024 | seekingalpha.comCanada’s updated guidance on ESG-related investment fund disclosureApril 18, 2024 | theglobeandmail.comVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328April 3, 2024 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328April 1, 2024 | msn.comThe Top 3 ETFs to Buy in March 2024March 7, 2024 | investorplace.com11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher YieldsFebruary 28, 2024 | markets.businessinsider.comNavigate to Success With These 4 Pharma Stocks to BuyFebruary 28, 2024 | stocknews.comThe 3 Hottest Healthcare ETFs to Buy in 2024February 26, 2024 | investorplace.comPPH VanEck Pharmaceutical ETFFebruary 21, 2024 | seekingalpha.comHealthcare dealmakers see increased M&A, valuations in 2024: KPMGFebruary 20, 2024 | msn.comBig Pharma earnings season in spotlight amid positive sentimentJanuary 28, 2024 | msn.com5 ETF Zones Scaling New Highs at the Start of 2024January 8, 2024 | finance.yahoo.comPfizer in 2024: What to expect?December 29, 2023 | msn.comGilead in 2024: What to expect?December 28, 2023 | msn.comVanEck Pharmaceutical ETF Announces Dividend of $0.31 (NASDAQ:PPH)December 27, 2023 | marketbeat.comVontobel Holding Ltd. Has $799,000 Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)December 26, 2023 | marketbeat.comETFs to buy and sell as the GLP-1 craze boomsDecember 6, 2023 | cnbc.com10 Best Performing Healthcare ETFs in 2023November 14, 2023 | uk.finance.yahoo.comPharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your PortfolioNovember 6, 2023 | msn.comPPH ETF Stock Price HistoryNovember 1, 2023 | investing.comPPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling PortfolioOctober 29, 2023 | msn.com3 Resilient Pharma Stocks to Buy This WeekOctober 26, 2023 | stocknews.comOzempic craze drives big flows into pharmaceutical, Danish fundsOctober 25, 2023 | msn.comEli Lilly, Novo among notable decliners in pharma weaknessOctober 19, 2023 | seekingalpha.comWhich of these 3 Pharma Stocks Should You Buy, Hold or Sell?September 15, 2023 | stocknews.comHRT Financial LP Increases Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)September 4, 2023 | marketbeat.comWhy is big pharma unmoved despite Medicare pricing threat?September 3, 2023 | msn.comShort Interest in VanEck Pharmaceutical ETF (NASDAQ:PPH) Drops By 17.0%August 28, 2023 | marketbeat.comPharma ETF (PPH) Hit a 52-Week HighAugust 10, 2023 | au.news.yahoo.comRaymond James & Associates Cuts Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)July 27, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Trims Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)July 24, 2023 | marketbeat.comPPH - VanEck Pharmaceutical ETFJuly 6, 2023 | finance.yahoo.comInternational Assets Investment Management LLC Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH)July 4, 2023 | marketbeat.comSanofi: EPS Momentum Driven By Dupixent, Vaccines Day On TapJune 29, 2023 | msn.comVanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Vontobel Holding Ltd.June 26, 2023 | marketbeat.com Get VanEck Pharmaceutical ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter. Email Address PPH Media Mentions By Week PPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PPH News Sentiment▼0.931.56▲Average Manufacturing News Sentiment PPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PPH Articles This Week▼20▲PPH Articles Average Week Get VanEck Pharmaceutical ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIB News IBB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PPH) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
